Celgene: A Winner in Biopharma

Posted on

Celgene has been one of the dominant biotech players in recent history. Its successful R&D and acquisitions have made the company a contender for the industry’s pole position, and its growing commercialization capabilities have effectively utilized its assets to create a diversified growth profile with a 2020 sales CAGR of almost 20%.

Bio-Pappel: Bringing sustainability to the forefront of Mexican manufacturing

Bio-Pappel, the leading producer of paper and paper-based products in Latin America, underwent a radical shift starting in 2011 to become a truly sustainable company. With 27 production plants in Mexico, United States, and Colombia, and a production process that relies on the use of 100%-recycled inputs, Bio-Pappel is well-positioned to continue generating and capturing value for its customers.